Can We Create Companion Diagnostics In Oncology With What We Know About Biomarkers?

As we continue our discussion between Steve Buckanavage, Kineticos’ Operating Executive, and Christopher Heery, M.D., CMO at Precision Biosciences, we discuss Biomarkers and their impact in diagnosing individual patients versus segmenting patient populations. To read the whole article, click the link below. (2019)